Covered recipient · General Payments record
AHMAREEN BATEN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$992.13
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $694.25 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $162.74 | 11 |
| Lilly USA, LLC | $96.70 | 5 |
| SK Life Science, Inc. | $78.19 | 3 |
| CATALYST PHARMACEUTICALS, INC. | $63.82 | 3 |
| PFIZER INC. | $52.40 | 2 |
| EISAI INC. | $47.20 | 2 |
| JAZZ PHARMACEUTICALS INC. | $38.70 | 1 |
| Lundbeck LLC | $36.32 | 2 |
| BANNER LIFE SCIENCES, LLC | $33.35 | 2 |
| UCB, Inc. | $31.92 | 1 |
| Biogen, Inc. | $22.50 | 1 |
| Neurelis, Inc. | $16.94 | 1 |
| ACADIA Pharmaceuticals Inc | $13.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.39 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289681 | CMS |
| ABBVIE INC. | $20.86 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289683 | CMS |
| ABBVIE INC. | $12.61 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289685 | CMS |
| ABBVIE INC. | $14.85 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289687 | CMS |
| ABBVIE INC. | $9.84 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289689 | CMS |
| ABBVIE INC. | $21.49 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289691 | CMS |
| ABBVIE INC. | $20.73 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289693 | CMS |
| ABBVIE INC. | $11.11 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289695 | CMS |
| ABBVIE INC. | $6.59 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289697 | CMS |
| ABBVIE INC. | $6.83 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289699 | CMS |
| ABBVIE INC. | $23.44 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103289701 | CMS |
| ACADIA Pharmaceuticals Inc | $13.47 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147963079 | CMS |
| BANNER LIFE SCIENCES, LLC | $18.99 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147030513 | CMS |
| BANNER LIFE SCIENCES, LLC | $14.36 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147031820 | CMS |
| Biogen, Inc. | $22.50 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104876710 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $20.44 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144449954 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $23.39 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144449956 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $19.99 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144449958 | CMS |
| Eisai Inc. | $22.18 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110727001 | CMS |
| Eisai Inc. | $25.02 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110727003 | CMS |
| JAZZ PHARMACEUTICALS INC. | $38.70 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150236264 | CMS |
| Lilly USA, LLC | $21.91 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136005413 | CMS |
| Lilly USA, LLC | $15.33 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136010769 | CMS |
| Lilly USA, LLC | $24.75 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136012153 | CMS |
| Lilly USA, LLC | $18.70 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136010771 | CMS |
| Lilly USA, LLC | $16.01 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136014877 | CMS |
| Lundbeck LLC | $22.99 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145895599 | CMS |
| Lundbeck LLC | $13.33 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145895601 | CMS |
| Neurelis, Inc. | $16.94 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145633162 | CMS |
| PFIZER INC. | $25.03 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131079289 | CMS |
| PFIZER INC. | $27.37 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131324335 | CMS |
| SK Life Science, Inc. | $32.58 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154151811 | CMS |
| SK Life Science, Inc. | $16.58 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154151825 | CMS |
| SK Life Science, Inc. | $29.03 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154151907 | CMS |
| UCB, Inc. | $31.92 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143034267 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.